Disclosed positions

Estimated from their latest filings — positions may have changed since

$21.2K

combined est. value

Stock	Shares	Price	Value	Weight	As of
CADLCandel Therapeutics, Inc.	2,141	$9.88	$21.2K	100%	2025-06-25

CADL

Candel Therapeutics, Inc.

$21.2K

2,141 sh

All filings on record

Every Form 4 transaction we track for this filer

all 1buys 0sells 0

Stock	Transaction	Date	~6mo later
CADLCandel Therapeutics, Inc.	Grant $10.0K · 2,141 sh	2025-06-25	—

CADLGrant

2025-06-25 · Candel Therapeutics, Inc.

$10.0K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.